<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>
pmid: 31898537
pmc: PMC6941350
Abstract Background Ewing sarcoma is a malignancy of primitive cells, possibly of mesenchymal origin. It is probable that genetic perturbations other than EWS-FLI1 cooperate with it to produce the tumor. Sequencing studies identified STAG2 mutations in approximately 15% of cases in humans. In the present study, we hypothesize that loss of Stag2 cooperates with EWS-FLI1 in generating sarcomas derived from murine mesenchymal stem cells (MSCs). Methods Mice bearing an inducible EWS-FLI1 transgene were crossed to p53−/− mice in pure C57/Bl6 background. MSCs were derived from the bone marrow of the mice. EWS-FLI1 induction and Stag2 knockdown were achieved in vitro by adenovirus-Cre and shRNA-bearing pGIPZ lentiviral infection, respectively. The cells were then treated with ionizing radiation to 10 Gy. Anchorage independent growth in vitro was assessed by soft agar assays. Cellular migration and invasion were evaluated by transwell assays. Cells were injected with Matrigel intramuscularly into C57/Bl6 mice to test for tumor formation. Results Primary murine MSCs with the genotype EWS-FLI1 p53−/− were resistant to transformation and did not form tumors in syngeneic mice without irradiation. Stag2 inhibition increased the efficiency and speed of sarcoma formation significantly in irradiated EWS-FLI1 p53−/− MSCs. The efficiency of tumor formation was 91% for cells in mice injected with Stag2-repressed cells and 22% for mice receiving cells without Stag2 inhibition (p < .001). Stag2 knockdown reduced survival of mice in Kaplan-Meier analysis (p < .001). It also increased MSC migration and invasion in vitro but did not affect proliferation rate or aneuploidy. Conclusion Loss of Stag2 has a synergistic effect with EWS-FLI1 in the production of sarcomas from murine MSCs, but the mechanism may not relate to increased proliferation or chromosomal instability. Primary murine MSCs are resistant to transformation, and the combination of p53 null mutation, EWS-FLI1, and Stag2 inhibition does not confer immediate conversion of MSCs to sarcomas. Irradiation is necessary in this model, suggesting that perturbations of other genes beside Stag2 and p53 are likely to be essential in the development of EWS-FLI1-driven sarcomas from MSCs.
p53, Oncogene Proteins, Fusion, Molecular biology, Gene Expression, Cell Cycle Proteins, Biochemistry, Mice, Cell Movement, Pathology, RC254-282, Mesenchymal stem cell, Mice, Knockout, Cell Cycle, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Life Sciences, Sarcoma, Chemistry, Cell Transformation, Neoplastic, Oncology, Medicine, RNA Interference, Research Article, Pulmonary and Respiratory Medicine, Ewing's Sarcoma, Cell biology, Epithelial-Mesenchymal Transition, Immunology, Mice, Transgenic, Sarcoma, Ewing, Cancer research, Mouse model, Sarcoma Research and Treatment, Matrigel, In vitro, Cell Line, Tumor, Biochemistry, Genetics and Molecular Biology, Health Sciences, Molecular Mechanisms of Kidney Development and Disease, Genetics, Animals, Bone marrow, Molecular Biology, Biology, EWS-FLI1, Cell Proliferation, Chromosome Aberrations, Gene knockdown, Proto-Oncogene Protein c-fli-1, FOS: Clinical medicine, Mesenchymal Stem Cells, Genes, p53, Disease Models, Animal, Cancer Stem Cells and Tumor Metastasis, FOS: Biological sciences, Stag2, Mesenchymal stem cells, Cell culture, Angiogenesis, RNA-Binding Protein EWS, Ewing sarcoma
p53, Oncogene Proteins, Fusion, Molecular biology, Gene Expression, Cell Cycle Proteins, Biochemistry, Mice, Cell Movement, Pathology, RC254-282, Mesenchymal stem cell, Mice, Knockout, Cell Cycle, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Life Sciences, Sarcoma, Chemistry, Cell Transformation, Neoplastic, Oncology, Medicine, RNA Interference, Research Article, Pulmonary and Respiratory Medicine, Ewing's Sarcoma, Cell biology, Epithelial-Mesenchymal Transition, Immunology, Mice, Transgenic, Sarcoma, Ewing, Cancer research, Mouse model, Sarcoma Research and Treatment, Matrigel, In vitro, Cell Line, Tumor, Biochemistry, Genetics and Molecular Biology, Health Sciences, Molecular Mechanisms of Kidney Development and Disease, Genetics, Animals, Bone marrow, Molecular Biology, Biology, EWS-FLI1, Cell Proliferation, Chromosome Aberrations, Gene knockdown, Proto-Oncogene Protein c-fli-1, FOS: Clinical medicine, Mesenchymal Stem Cells, Genes, p53, Disease Models, Animal, Cancer Stem Cells and Tumor Metastasis, FOS: Biological sciences, Stag2, Mesenchymal stem cells, Cell culture, Angiogenesis, RNA-Binding Protein EWS, Ewing sarcoma
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 13 | |
popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |